Morgan Stanley analyst Erin Wright initiates coverage on Elevance Health (NYSE:ELV) with a Overweight rating and announces Price Target of $643.
Morgan Stanley Initiates Coverage On Elevance Health With Overweight Rating, Announces Price Target of $643
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.